Found
Status: Reported · 2 row(s) on file · checked 2026-08-25
A data file, not a finished review: the prices below are third-party Reported figures with their source and check date. They move to First-party only after our own dated walk of Found's pages — and this page will say so when they do.
Reported pricing on file · semaglutide, tirzepatide
- Listed without a rank
- On the read of 2026-09-17, Found’s public pages print no rankable semaglutide, tirzepatide price — 'Cash plans from $169/mo' for the GLP-1 program, 'billed per 28-day cycle', '*Pricing based on 12-month plans paid up-front'; 'Monthly plans start at ... $289/mo for cash-pay'; medication included on compounded plans, bu. Nothing on this site averages, estimates or infers a price a provider did not publish; the program is listed, never ranked.
- Provenance
- joinfound.com · checked 2026-08-25
Provider scorecard — the fields the sprint fills
| Pharmacy on file | not yet on file — queued |
| Pharmacy type | 503A (provider-stated, unnamed) |
| States served | queued — unconfirmed coverage keeps state pages noindexed |
| Membership · consult fee | queued · queued |
| Dose-change policy | queued |
| Cancellation terms | queued |
| Shipping | queued |
| Intro price (first month/period) | — |
| Medication included in price | — not separately recorded |
| Offer conditions on file | “from $99” is a starting claim, not a standard all-in recurring price; membership/program options from $49 |
| Offer expiry / scheduled recheck | — |
| Support-response test | pending — standardized three-question timed email test, per the sprint |
| Cancellation walkthrough | pending — scripted cancel-and-document test, per the sprint |
| Update history | row verified/recorded 2026-08-25 · file regenerated 2026-09-20 |
Watch-outs recorded by trackers
- $99/mo prepaid annual with insurance + copay
- Read 2026-09-17: 'Cash plans from $169/mo' for the GLP-1 program, 'billed per 28-day cycle', '*Pricing based on 12-month plans paid up-front'; 'Monthly plans start at ... $289/mo for cash-pay'; medication included on compounded plans, but no tirzepatide-specific price is printed; 'No plans available' for California.
What we have not verified
The standing (non-promo) rate at every dose; whether the figure is all-inclusive; the dispensing pharmacy and its 503A/503B status; state availability; cancellation terms. Until those are recorded first-party, Found appears in ranked tables at its reported figure with a Reported chip, never a Verified one — the same rule applied to every program here, including every partner program — placements are labeled “Editor’s Pick” and disclosed.
Visit Found → outbound link carries our tracking tags; see the affiliate disclosure